- Home
- LTBR vs MDXG Comparison
LTBR vs MDXG Comparison
Compare LTBR & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LTBR | MDXG |
|---|---|---|
| Founded | 1992 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 575.6M | 530.2M |
| IPO Year | 2015 | 2007 |
Fundamental Metrics
Financial Performance| Metric | LTBR | MDXG |
|---|---|---|
| Price | $11.38 | $3.62 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 762.1K | ★ 1.6M |
| Earning Date | 04-27-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.29 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $418,630,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $13.02 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 19.99 |
| 52 Week Low | $9.78 | $3.03 |
| 52 Week High | $31.34 | $7.99 |
Technical Indicators
Market Signals| Indicator | LTBR | MDXG |
|---|---|---|
| Relative Strength Index (RSI) | 44.38 | 46.57 |
| Support Level | $11.13 | $3.45 |
| Resistance Level | $11.53 | $3.80 |
| Average True Range (ATR) | 0.78 | 0.12 |
| MACD | -0.16 | 0.02 |
| Stochastic Oscillator | 22.20 | 34.29 |
Price Performance
Historical ComparisonAbout LTBR Lightbridge Corporation
Lightbridge Corp is a United States-based nuclear fuel technology company. The business activity of the firm is functioned through one business segment, which is the development and commercialization of its nuclear fuel. The Nuclear Fuel Technology segment develops next generation nuclear fuel technology that increases the power output of commercial reactors and reduces the cost of generating electricity. Geographically, its operations are functioned through the region of Unites States.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.